For any DOS 10/1/26 and thereafter the following oncology drug will  require a prior authorization.

What is the new code?

• colony stimulating factor medication
• J2860- Injection, siltuximab, 10 mg

Which platform types does this change apply to?

• Commercial- all states
• Medicare Advantage- all states
• UHC commercial plans in the following states: New York, New Jersey, PA, TX, Arizona (does not include the full list) -please check with your UHC Community Plan that you accept.in your office/facility.
• UHC- exchange plans in the following states: New York, New Jersey, Alabama, FL, Colorado (does not include a full list) please check with the UHC individual exchange plan for your state.

Find this content useful? Follow me for more!

• UHC oncology coding prior auth update
• Highmark BCBS: update-molecular lab prior auth process
• Cigna: BH Appeal update
• MA medicaid weight loss drug coverage update
• Aetna: usage of modifier CT and reimbursement